SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-028099
Filing Date
2009-07-31
Accepted
2009-07-31 10:22:37
Documents
36
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q c52635e10vq.htm 10-Q 370904
2 EX-11 c52635exv11.htm EX-11 10740
3 EX-12 c52635exv12.htm EX-12 9947
4 EX-31.1 c52635exv31w1.htm EX-31.1 8475
5 EX-31.2 c52635exv31w2.htm EX-31.2 8721
6 EX-32 c52635exv32.htm EX-32 3395
  Complete submission text file 0000950123-09-028099.txt   6363000

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT lly-20090630.xml EX-101.INS 563930
8 EX-101 SCHEMA DOCUMENT lly-20090630.xsd EX-101.SCH 15266
9 EX-101 CALCULATION LINKBASE DOCUMENT lly-20090630_cal.xml EX-101.CAL 701738
10 EX-101 LABELS LINKBASE DOCUMENT lly-20090630_lab.xml EX-101.LAB 1513985
11 EX-101 PRESENTATION LINKBASE DOCUMENT lly-20090630_pre.xml EX-101.PRE 1062237
12 EX-101 DEFINITION LINKBASE DOCUMENT lly-20090630_def.xml EX-101.DEF 1045245
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 09975676
SIC: 2834 Pharmaceutical Preparations